Moreover, AML patients exhibiting other expression patterns (e.g. CD19 expression without CD7 expression or abnormal CD33 and CD13 expression patterns without CD7 expression) should also be analyzed using an SVM in order to determine the scope of its utility. Here, CD7 is linked to acute myeloid leukemia.